CENTER VALLEY, Pa., Feb. 21,
2018 /PRNewswire/ -- Aesculap, Inc. is pleased to announce
the asset acquisition of Dextera Surgical Inc. Aesculap is an
industry expert in providing comprehensive solutions and
differentiated technologies to help meet the needs of the changing
healthcare environment.
Dextera designs, manufactures and markets proprietary medical
devices for surgical procedures, including surgical staplers and
innovative devices for coronary artery bypass graft (CABG) surgery.
Aesculap will oversee operations in Redwood City, CA to continue the manufacturing
and distribution of Dextera's products.
Through the acquisition, Aesculap expands its portfolio of
premium solutions for beating heart coronary and video-assisted
thoracic surgery. The innovative MicroCutter 5/80 stapler,
PAS-Port® proximal anastomosis system, C-Port® distal anastomosis
system and technology portfolio supports Aesculap's growth in the
cardio-thoracic surgery market.
About Aesculap, Inc.
Aesculap, Inc., a B. Braun
company, is part of a 180-year-old global organization focused on
meeting the needs of an ever-changing healthcare community. Through
close collaboration with its customers, Aesculap provides advanced
technologies for general surgery, neurosurgery and closure
technologies. Aesculap continues a proud heritage of leadership and
responsiveness as we strive to deliver products and services that
improve the quality of patients' lives. For more information, call
800-282-9000 or visit aesculapusa.com.
View original content with
multimedia:http://www.prnewswire.com/news-releases/aesculap-inc-acquires-dextera-surgical-inc-300601974.html
SOURCE Aesculap, Inc.